People · Operator
Named in public records as an officer, director or promoter · active 2023–2024 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Eikonoklastes Therapeutics, Inc. | — | Pharmaceuticals | Series A | $25.0M | $43.9M | 2023 |
Meyer Frucher at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Meyer Frucher on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Johnson | 1 | 9 |
| Joseph Nolan | 1 | 5 |
| Samuel Lee | 1 | 4 |
| Thomas Finn | 1 | 3 |
| Neel Patel | 1 | 2 |
| Bruce Halpryn | 1 | 1 |
| Kenneth Morand | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.